Cargando…

Comment on “Arthritis due to monkeypox virus: A case report” by Lombès A et al. Joint Bone Spine. 2023;90:105492

Detalles Bibliográficos
Autores principales:	Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de rhumatologie. Published by Elsevier Masson SAS. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774762/ https://www.ncbi.nlm.nih.gov/pubmed/36535549 http://dx.doi.org/10.1016/j.jbspin.2022.105518

Ejemplares similares

Answer to Mungmunpuntipantip et al. Joint Bone Spine 2023;90:105518
por: Lombès, Amélie, et al.
Publicado: (2023)

Comment on monkeypox and perioperative context
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Monkeypox and pregnancy: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Monkeypox and emergency medicine clinicians
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Syphilis and Monkeypox: An Issue in Sexual Medicine
por: MUNGMUNPUNTIPANTIP, Rujittika, et al.
Publicado: (2022)

Monkeypox Outbreak and Implications for Dental Practice
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Monkeypox and oropharyngeal and laryngeal manifestation: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Hematuria as a possible clinical presentation in monkeypox
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Monkeypox, pregnancy, and evidence of vertical transmission: reply
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Monkeypox Outbreaks in Non-Endemic Countries: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Sexual transmission in monkeypox: A discussion on the possibility
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

China and monkeypox: Correspondence
por: Keebayoon, Amnuay, et al.
Publicado: (2022)

Marijauna (Cannabis sativa L.) and roles against monkeypox
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

RE: Oral Manifestations of Monkeypox: A Report of Two Cases
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The first few cases of monkeypox infection in non-endemic countries: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Monkeypox in HIV Infected Cases: A Summary on Clinical Presentation of 27 Cases
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Telemedicine in Spine Surgery During COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Peripheral Blood Smears in COVID-19: A Comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comment on “Inflawell, neutrophil-to-lymphocyte ratio and COVID-19”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on "Knowledge, Attitude, and Acceptability of COVID-19 Vaccine"
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on bibliometric and visual analysis of vaccination hesitancy research
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Monkeypox Disease Outbreak (2022): Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on Fetal Gestational Age Determination Using Ultrasound Placental Thickness
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Aspects scanographiques de la pneumopathie à COVID-19”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comments on: “Spectrum of Neurological Complications Following COVID-19 Vaccination in India”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Polymorphism of the CYP2C9 and VKORC1 genes: a comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comment on “Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Vaccine, infection, COVID-19-related loss of training time and athletes”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “telomerase reverse transcriptase rs2736098 and rs2736100 in bladder cancer”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19-induced acute kidney injury and chronic kidney disease: comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Echocardiographic Evolution of Posterolateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment to: Post-vaccination incidence and side effects of COVID-19 in a cohort of Brazilian healthcare professionals: an internet-based survey
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2umruq3n3cv0vik3g325900flm